First Time Loading...

ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 3.44 USD -6.27% Market Closed
Updated: Jul 21, 2024
Have any thoughts about
ADC Therapeutics SA?
Write Note

ADC Therapeutics SA
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ADC Therapeutics SA
Operating Income Peer Comparison

Comparables:
ACIU
CRSP
BSLN
IDIA
KURN

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
ADC Therapeutics SA
NYSE:ADCT
Operating Income
-$166m
CAGR 3-Years
9%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Operating Income
-CHf56.1m
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Operating Income
-$298.6m
CAGR 3-Years
9%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Operating Income
CHf19.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Idorsia Ltd
SIX:IDIA
Operating Income
-CHf543.1m
CAGR 3-Years
-10%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Operating Income
-CHf8.7m
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
N/A

See Also

What is ADC Therapeutics SA's Operating Income?
Operating Income
-166m USD

Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Operating Income amounts to -166m USD.

What is ADC Therapeutics SA's Operating Income growth rate?
Operating Income CAGR 5Y
-6%

Over the last year, the Operating Income growth was -37%. The average annual Operating Income growth rates for ADC Therapeutics SA have been 9% over the past three years , -6% over the past five years .